Fortress Biotech (FBIO) Stock Forecast, Price & News

Fortress Biotech (NASDAQ:FBIO) Frequently Asked Questions

Is Fortress Biotech a buy right now?

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Fortress Biotech in the last year. There are currently 5 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Fortress Biotech stock.
View analyst ratings for Fortress Biotech or view top-rated stocks.

Are investors shorting Fortress Biotech?

Fortress Biotech saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 2,620,000 shares, an increase of 42.4% from the April 15th total of 1,840,000 shares. Based on an average daily volume of 593,700 shares, the short-interest ratio is currently 4.4 days. Currently, 3.1% of the company's shares are short sold.
View Fortress Biotech's Short Interest.

When is Fortress Biotech's next earnings date?

Fortress Biotech is scheduled to release its next quarterly earnings announcement on Monday, August 15th 2022.
View our earnings forecast for Fortress Biotech.

How were Fortress Biotech's earnings last quarter?

Fortress Biotech, Inc. (NASDAQ:FBIO) issued its earnings results on Thursday, May, 12th. The biopharmaceutical company reported ($0.18) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.28) by $0.10. Fortress Biotech had a negative net margin of 88.31% and a negative trailing twelve-month return on equity of 32.56%. During the same period in the previous year, the company earned ($0.11) earnings per share.
View Fortress Biotech's earnings history.

What price target have analysts set for FBIO?

5 brokerages have issued 1-year target prices for Fortress Biotech's stock. Their forecasts range from $6.00 to $20.00. On average, they anticipate Fortress Biotech's share price to reach $11.00 in the next twelve months. This suggests a possible upside of 1,120.1% from the stock's current price.
View analysts' price targets for Fortress Biotech or view top-rated stocks among Wall Street analysts.

Who are Fortress Biotech's key executives?

Fortress Biotech's management team includes the following people:

• Dr. Lindsay Allan Rosenwald, Exec. Chairman, Pres & CEO (Age 67, Pay $576.65k)
• Mr. Michael S. Weiss Esq., Vice Chairman & Exec. Vice Chairman of Strategic Devel. (Age 56, Pay $576.63k)
• Ms. Robyn M. Hunter, CFO, Treasurer & Corp. Sec. (Age 60, Pay $583.11k)
• Dr. George C. Avgerinos, Sr. VP of Biologics Operations (Age 68, Pay $386.5k)
• Dr. Thomas F. Schaible, Project Leader of Inflammatory Bowel Disease

Who are some of Fortress Biotech's key competitors?

Some companies that are related to Fortress Biotech include Amgen (AMGN), Gilead Sciences (GILD), Regeneron Pharmaceuticals (REGN), Vertex Pharmaceuticals (VRTX), Biogen (BIIB), Seagen (SGEN), Incyte (INCY), Alnylam Pharmaceuticals (ALNY), BioMarin Pharmaceutical (BMRN), Exact Sciences (EXAS), United Therapeutics (UTHR), Repligen (RGEN), Neurocrine Biosciences (NBIX), Exelixis (EXEL) and Halozyme Therapeutics (HALO).
View all of FBIO's competitors.

What other stocks do shareholders of Fortress Biotech own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Fortress Biotech investors own include Sorrento Therapeutics (SRNE), VBI Vaccines (VBIV), Novavax (NVAX), Advanced Micro Devices (AMD), OPKO Health (OPK), TG Therapeutics (TGTX), Vaxart (VXRT), NVIDIA (NVDA), Pfizer (PFE) and Dynavax Technologies (DVAX).

What is Fortress Biotech's stock symbol?

Fortress Biotech trades on the NASDAQ under the ticker symbol "FBIO."

Who are Fortress Biotech's major shareholders?

Fortress Biotech's stock is owned by a variety of institutional and retail investors. Top institutional investors include Nantahala Capital Management LLC (8.26%), Vanguard Group Inc. (5.30%), BlackRock Inc. (4.40%), State Street Corp (1.21%), Renaissance Technologies LLC (1.03%) and Northern Trust Corp (0.62%). Company insiders that own Fortress Biotech stock include Eric K Rowinsky, Lindsay A Md Rosenwald, Malcolm Hoenlein and Robyn Hunter.
View institutional ownership trends for Fortress Biotech.

Which major investors are selling Fortress Biotech stock?

FBIO stock was sold by a variety of institutional investors in the last quarter, including Nantahala Capital Management LLC, BlackRock Inc., Northern Trust Corp, Group One Trading L.P., HAP Trading LLC, Vanguard Group Inc., Kestra Advisory Services LLC, and Cutler Group LP.
View insider buying and selling activity for Fortress Biotech or view top insider-selling stocks.

Which major investors are buying Fortress Biotech stock?

FBIO stock was bought by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Acadian Asset Management LLC, GSA Capital Partners LLP, State Street Corp, National Asset Management Inc., Envestnet Asset Management Inc., Goldman Sachs Group Inc., and Charles Schwab Investment Management Inc.. Company insiders that have bought Fortress Biotech stock in the last two years include Lindsay A Md Rosenwald, and Malcolm Hoenlein.
View insider buying and selling activity for Fortress Biotech or or view top insider-buying stocks.

How do I buy shares of Fortress Biotech?

Shares of FBIO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Fortress Biotech's stock price today?

One share of FBIO stock can currently be purchased for approximately $0.90.

How much money does Fortress Biotech make?

Fortress Biotech has a market capitalization of $96.84 million and generates $68.79 million in revenue each year. The biopharmaceutical company earns $-64.70 million in net income (profit) each year or ($0.860010) on an earnings per share basis.

How many employees does Fortress Biotech have?

Fortress Biotech employs 173 workers across the globe.

What is Fortress Biotech's official website?

The official website for Fortress Biotech is www.fortressbiotech.com.

How can I contact Fortress Biotech?

Fortress Biotech's mailing address is 2 GANSEVOORT STREET 9TH FLOOR, NEW YORK NY, 10014. The biopharmaceutical company can be reached via phone at (781) 652-4500, via email at [email protected], or via fax at 781-652-4545.